Total raised
$20.5M
Last: Convertible Debt 2022-03
Stage
Acquired
Founded
2018
Headcount
28
HQ
Ramat Gan
Sector
Health Tech & Life Sciences
About
Innovalve Bio Medical is an early-stage medical device company developing catheter-based heart valve therapies.
The company has developed an artificial mitral valve that can be replaced using a minimally invasive catheter to help treat patients with heart disease. The company has achieved successful results in experiments on animals.
The company grew out of inventions and patents developed by Sheba Medical Center experts Professor Ehud Raanani, the director of Sheba’s Cardiovascular and Thoracic Center, and Dr. Boris Orlev, head of the center’s Mitral Valve Surgery Unit.
Funding history · 3 rounds · $20.5M total
2022-03
Convertible Debt
$5.0M
2021-06
Series A
$5.0M
2020-08
Series A
$10.5M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of Innovalve Bio Medical?
- Innovalve Bio Medical is an early-stage medical device company specializing in catheter-based heart valve therapies, specifically developing an artificial mitral valve for minimally invasive replacement.
- When was Innovalve Bio Medical founded?
- Innovalve Bio Medical was founded in August 2018.
- What is the current status of Innovalve Bio Medical?
- Innovalve Bio Medical is currently inactive, having been acquired by Edwards Lifesciences in July 2024, after which it ceased to operate.
- How much funding has Innovalve Bio Medical raised in total?
- Innovalve Bio Medical has raised a total of $20,500,000 across multiple funding rounds. For a full financing history, refer to startupim.
- Which investors participated in Innovalve Bio Medical's Series A round in August 2020?
- The Series A round in August 2020 was led by ALIVE Israel Healthtech Fund, with participation from OurCrowd and Edwards Lifesciences.
- When did Innovalve Bio Medical receive its last known funding round?
- Innovalve Bio Medical received its last known funding round in March 2022, a convertible debt round of $5,000,000 from OurCrowd.
- What was the acquisition amount for Innovalve Bio Medical by Edwards Lifesciences?
- Innovalve Bio Medical was acquired by Edwards Lifesciences in July 2024 for $300,000,000.
- What is the employee count for Innovalve Bio Medical?
- Innovalve Bio Medical has an employee count in the range of 11-50, with an exact count of 28 employees.
- What is the origin of Innovalve Bio Medical's core technology?
- Innovalve Bio Medical's core technology originated from inventions and patents developed by Professor Ehud Raanani and Dr. Boris Orlev of Sheba Medical Center.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
medical-technologiescathetersheart-diseasesminimally-invasivemedical-devicesvalvescardiology